Dan DeStefano

Dan DeStefano

Formerly at Shire Pharmaceuticals
Head of Global Medical Affairs Systems and Operations

Successful Project from Conception to Go-Live

Marcel worked with my team from concept to deployment in our launch of Veeva's CRM tool for our Medical Science Liaisons. From the beginning, Marcel was an excellent partner, skilled at helping a variety of different user segments understand the features, capabilities, and limitations of the platform, and helped us understand how different user roles would interact with the system.

Marcel's communication style and product knowledge were excellent, and his input in the early phases as well as quick thinking on some issues that arose as we approached deployment helped to make our project a success. I would highly recommend Marcel for his expertise and product understanding, as well as his consulting skills, and hope I have a chance to work with him again on future efforts.

 

04c4b38

Daniel Evans, MBA

Shire Pharmaceuticals
Associate Director Global Systems and Ops Strategy, Medical Affairs

Expert Added Substantial Value for Our Team

Prior to the Global Medical Affairs (GMA) implementation of Veeva, Shire's CRM deployments had been regional and focused on commercial activities. We needed to deploy one global system for tracking interactions between customers and medical personnel.  Shire chose Veeva CRM to leverage existing knowledge and experience, but needed an expert to configure it correctly.  We partnered with Marcel and team to help design and build to our unique requirements. 
 
Since going live, the global platform has been very well accepted by our user base.  We have user engagement from countries which have historically resisted, largely due to the quick turnaround to get the system into end users' hands following various successful UAT/Feedback sessions. 
 
Our new system has added substantial value for our Medical Affairs team.  We can reliably report on activities across the globe from one system for the first time.  We can report across ~40 products and disease states, pull content directly from Veeva Vault to use in CLM, and view activity in all 28 countries where our users currently operate.  We now have the ability to streamline our on-boarding process.  Even more importantly - we're in excellent position to scale as needed.